// App-Quantinova.ai

P24.03 : Dynamic Circulating Tumor DNA Interim Results From The ALKternate Clinical Trial

Researchers

Presenter

  • M. Itchins

Principal Investigators

  • S. Liang

  • T. Barnes

  • V. Chin

  • A. Nagrial

  • G. Peters

  • C. Lewis

  • T. Shaffer

  • M. Li

  • S. Clarke

  • B. Li

  • C. Brown

  • B. Solomon

  • N. Pavlakis

Medical Centers

  • Medical Oncology, Peter Maccallum Cancer Centre, Melbourne/VIC/AU

  • Medical Oncology, 1. Macarthur Cancer Therapy Centre, Campbelltown/NSW/AU

  • Medical Oncology, Crown Princess Mary Cancer Centre, Westmead/NSW/AU

  • Canberra Hospital, Garran/ACT/AU

  • Medical Oncology, Royal North Shore Hospital, St Leonards/NSW/AU

  • Medical Oncology, Sydney Adventist Hospital, Wahroonga/AU

  • Medical Oncology, Liverpool Cancer Therapy Centre, Liverpool/AU

  • Medical Oncology, Memorial Sloan Kettering Cancer Center, New York/NY/US

  • Resolution Bioscience, Kirkland, WA

  • Medical Oncology, Chris O'Brien Lifehouse, Camperdown/AU

  • Medical Oncology, Nelune Comprehensive Cancer Centre, Randwick/NSW/AU

  • Medical Oncology, Northern Beaches Hospital, Frenchs Forrest/NSW/AU

  • Medical Oncology, The Kinghorn Cancer Centre, Darlinghurst/AU

  • 4Nhmrc Clinical Trials Centre, the University of Sydney, Camperdown/NSW/AU

Locations

  • United States

  • United Kingdom

  • Australia

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Lorlatinib

  • Crizotinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved